gptkbp:instanceOf
|
gptkb:psychotherapy
|
gptkbp:alternativeName
|
gptkb:vagus_nerve_stimulation
gptkb:VNS
|
gptkbp:approvalYear
|
1997
|
gptkbp:approvedBy
|
gptkb:FDA
|
gptkbp:category
|
implantable medical device
neuromodulation therapy
neurostimulation
|
gptkbp:contraindication
|
gptkb:arrhythmia
asthma
|
gptkbp:countryOfOperation
|
gptkb:Canada
gptkb:European_Union
gptkb:United_States
|
gptkbp:duration
|
30 seconds to 5 minutes per cycle
|
gptkbp:effect
|
anti-inflammatory response
autonomic nervous system modulation
improvement in mood
reduction in seizure frequency
|
gptkbp:frequency
|
20-30 Hz
|
https://www.w3.org/2000/01/rdf-schema#label
|
vagal nerve stimulation
|
gptkbp:inventedBy
|
gptkb:Jacob_Zabara
|
gptkbp:manufacturer
|
gptkb:LivaNova
gptkb:Cyberonics
|
gptkbp:mechanismOfAction
|
alteration of neurotransmitter release
modulation of neural activity
|
gptkbp:method
|
electrical stimulation
|
gptkbp:platform
|
implantable pulse generator
|
gptkbp:regulates
|
prescription only
|
gptkbp:relatedTo
|
gptkb:transcranial_magnetic_stimulation
deep brain stimulation
responsive neurostimulation
|
gptkbp:routeOfAdministration
|
surgical implantation
|
gptkbp:sideEffect
|
infection
cough
hoarseness
dyspnea
throat pain
|
gptkbp:studiedBy
|
gptkb:Alzheimer's_disease
obesity
inflammatory diseases
anxiety disorders
|
gptkbp:target
|
gptkb:vagus_nerve
|
gptkbp:usedFor
|
epilepsy
treatment-resistant depression
migraine
cluster headache
|
gptkbp:bfsParent
|
gptkb:Cushing_ulcer
|
gptkbp:bfsLayer
|
6
|